DE240975T1 - Menschliches gamma-interferon-spezifisches rezeptorprotein, antikoerper gegen dieses protein, verfahren zur herstellung dieses proteins und dieses antikoerpers und dieses protein und diesen antikoerper enthaltende zusammensetzungen. - Google Patents
Menschliches gamma-interferon-spezifisches rezeptorprotein, antikoerper gegen dieses protein, verfahren zur herstellung dieses proteins und dieses antikoerpers und dieses protein und diesen antikoerper enthaltende zusammensetzungen.Info
- Publication number
- DE240975T1 DE240975T1 DE198787105078T DE87105078T DE240975T1 DE 240975 T1 DE240975 T1 DE 240975T1 DE 198787105078 T DE198787105078 T DE 198787105078T DE 87105078 T DE87105078 T DE 87105078T DE 240975 T1 DE240975 T1 DE 240975T1
- Authority
- DE
- Germany
- Prior art keywords
- protein
- antibody
- production
- antibodies against
- specific receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL78444A IL78444A (en) | 1986-04-08 | 1986-04-08 | Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
DE240975T1 true DE240975T1 (de) | 1988-02-25 |
Family
ID=11056685
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE198787105078T Pending DE240975T1 (de) | 1986-04-08 | 1987-04-06 | Menschliches gamma-interferon-spezifisches rezeptorprotein, antikoerper gegen dieses protein, verfahren zur herstellung dieses proteins und dieses antikoerpers und dieses protein und diesen antikoerper enthaltende zusammensetzungen. |
DE3750342T Expired - Lifetime DE3750342T2 (de) | 1986-04-08 | 1987-04-06 | Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3750342T Expired - Lifetime DE3750342T2 (de) | 1986-04-08 | 1987-04-06 | Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4897264A (de) |
EP (1) | EP0240975B1 (de) |
JP (2) | JPH0787795B2 (de) |
AU (1) | AU614487B2 (de) |
CA (1) | CA1323728C (de) |
DE (2) | DE240975T1 (de) |
ES (1) | ES2061448T3 (de) |
IL (1) | IL78444A (de) |
ZA (1) | ZA872523B (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU561649B2 (en) * | 1981-02-27 | 1987-05-14 | F. Hoffmann-La Roche Ag | Antibodies to proteins |
CA1340698C (en) * | 1986-07-25 | 1999-08-10 | Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo | Preparation and uses of interferon-gamma |
CA1335792C (en) * | 1987-08-18 | 1995-06-06 | Chaim O. Jacob | Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease |
SE462364B (sv) * | 1988-09-30 | 1990-06-18 | Goeran Hansson | Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos |
IL88378A (en) * | 1988-11-14 | 2000-11-21 | Yeda Res & Dev | Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them |
DE69024398T2 (de) * | 1989-04-19 | 1996-06-13 | Hoffmann La Roche | Auflösbare Interferon-gamma-Rezeptoren sowie Verfahren zu deren Herstellung |
IL91562A0 (en) * | 1989-09-07 | 1990-04-29 | Yeda Res & Dev | Interferon-gamma receptor fragment and its production |
CA2070416A1 (en) * | 1989-10-23 | 1991-04-24 | Richard Ingram | Polypeptide inhibitors of gamma interferon |
DE69104356T2 (de) * | 1990-04-24 | 1995-03-02 | Schering Corp | Lösliche verkürzte interferon-gamma rezeptoren. |
DK0695189T3 (da) | 1992-12-29 | 1999-08-09 | Genentech Inc | Behandling af inflammatorisk tarmsygdom med IFN-gammainhibitorer |
GB2304342A (en) * | 1995-08-18 | 1997-03-19 | Univ Manchester | Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma |
US20020025316A1 (en) * | 1995-08-18 | 2002-02-28 | Ferguson Mark Williams James | Pharmaceutical composition containing inhibitors of interferon-gamma |
US6589750B2 (en) | 1997-02-20 | 2003-07-08 | Institut Pasteur | Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives |
CA2353520C (en) * | 1998-12-09 | 2006-04-25 | Protein Design Labs, Inc. | Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
AU2001250412A1 (en) * | 2000-03-31 | 2001-10-08 | Ipf Pharmaceuticals Gmbh | Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
US20050152902A1 (en) * | 2001-06-05 | 2005-07-14 | Advanced Biotherapy, Inc. | Treatment of diabetic retinopathy |
US20040086508A1 (en) * | 2001-06-05 | 2004-05-06 | Advanced Biotherapy, Inc. | Treatment of organ transplant rejection |
AU2003285874A1 (en) * | 2002-10-16 | 2004-05-04 | Amgen Inc. | HUMAN ANTI-IFN-Gamma NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-Gamma PATHWAY INHIBITORS |
ES2313039T3 (es) * | 2003-04-23 | 2009-03-01 | Medarex, Inc. | Composiciones y procedimientos para la terapia de enfermedad inflamatoria intestinal. |
EP2404615A1 (de) * | 2003-04-23 | 2012-01-11 | Medarex, Inc. | Humanisierte Antikörper gegen Interferon-alpha-Rezeptor-1 (IFNAR-1) |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
CA2545603A1 (en) | 2003-11-12 | 2005-05-26 | Biogen Idec Ma Inc. | Neonatal fc receptor (fcrn)-binding polypeptide variants, dimeric fc binding proteins and methods related thereto |
US20050276806A1 (en) * | 2004-06-15 | 2005-12-15 | Advanced Biotherapy, Inc. | Treatment of autism |
US20050276807A1 (en) * | 2004-06-15 | 2005-12-15 | Advanced Biotherapy, Inc. | Treatment of acne |
US7462454B2 (en) * | 2004-10-12 | 2008-12-09 | Advanced Biotherapy, Inc. | Treatment of herpes |
EP2311880A3 (de) | 2005-01-05 | 2011-07-27 | Biogen Idec MA Inc. | Cripto-bindende Moleküle |
US7526409B2 (en) * | 2005-10-07 | 2009-04-28 | Oracle International Corporation | Automatic performance statistical comparison between two periods |
JP2009516513A (ja) | 2005-11-21 | 2009-04-23 | ラボラトワール セローノ ソシエテ アノニム | ハイブリッド抗原結合分子の組成物及び製造方法並びにその使用 |
EP2591099B1 (de) | 2010-07-09 | 2020-11-18 | Bioverativ Therapeutics Inc. | Chimäre gerinnungsfaktoren |
US9738707B2 (en) | 2011-07-15 | 2017-08-22 | Biogen Ma Inc. | Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto |
MX350378B (es) | 2012-01-10 | 2017-09-05 | Biogen Ma Inc | Mejora del transporte de moleculas terapeuticas a traves de la barrera hematoencefalica. |
JP6772156B2 (ja) | 2015-02-04 | 2020-10-21 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 治療用分子を選択する方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL67896A (en) * | 1983-02-13 | 1987-03-31 | Yeda Res & Dev | Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them |
US4650674A (en) * | 1984-07-05 | 1987-03-17 | Genentech, Inc. | Synergistic cytotoxic composition |
US4751078A (en) * | 1985-07-03 | 1988-06-14 | Nagabhushan Tattanahalli L | Process for the purification of gamma interferon |
-
1986
- 1986-04-08 IL IL78444A patent/IL78444A/xx not_active IP Right Cessation
-
1987
- 1987-03-27 US US07/030,640 patent/US4897264A/en not_active Expired - Lifetime
- 1987-04-01 AU AU70958/87A patent/AU614487B2/en not_active Expired
- 1987-04-06 ES ES87105078T patent/ES2061448T3/es not_active Expired - Lifetime
- 1987-04-06 CA CA000533921A patent/CA1323728C/en not_active Expired - Lifetime
- 1987-04-06 EP EP87105078A patent/EP0240975B1/de not_active Expired - Lifetime
- 1987-04-06 DE DE198787105078T patent/DE240975T1/de active Pending
- 1987-04-06 DE DE3750342T patent/DE3750342T2/de not_active Expired - Lifetime
- 1987-04-08 JP JP62086749A patent/JPH0787795B2/ja not_active Expired - Lifetime
- 1987-04-08 ZA ZA872523A patent/ZA872523B/xx unknown
-
1994
- 1994-03-28 JP JP6057873A patent/JP2577868B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL78444A0 (en) | 1986-08-31 |
US4897264A (en) | 1990-01-30 |
ES2061448T3 (es) | 1994-12-16 |
DE3750342T2 (de) | 1994-12-08 |
EP0240975A3 (en) | 1989-09-13 |
EP0240975A2 (de) | 1987-10-14 |
JP2577868B2 (ja) | 1997-02-05 |
DE3750342D1 (de) | 1994-09-15 |
IL78444A (en) | 1992-05-25 |
JPH0770199A (ja) | 1995-03-14 |
AU7095887A (en) | 1987-10-15 |
CA1323728C (en) | 1993-10-26 |
AU614487B2 (en) | 1991-09-05 |
EP0240975B1 (de) | 1994-08-10 |
JPS6317699A (ja) | 1988-01-25 |
JPH0787795B2 (ja) | 1995-09-27 |
ZA872523B (en) | 1987-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE240975T1 (de) | Menschliches gamma-interferon-spezifisches rezeptorprotein, antikoerper gegen dieses protein, verfahren zur herstellung dieses proteins und dieses antikoerpers und dieses protein und diesen antikoerper enthaltende zusammensetzungen. | |
DE3382190D1 (de) | Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff. | |
DE3751537D1 (de) | Polypeptid- und Proteinderivate und Verfahren zu deren Herstellung. | |
DE68903482T2 (de) | Zement, verfahren zur herstellung dieses zements und verfahren zur herstellung von produkten mit diesem zement. | |
DE69125769D1 (de) | Nukleotidsequenz, die für ein Aussenmembran-Protein von Neisseria meningitidis kodiert und Verwendung dieses Proteins zur Herstellung von Impfstoffen | |
DE68912336D1 (de) | Hydrophobe proteinmikroteilchen und verfahren zur herstellung. | |
DE3585953D1 (de) | Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine. | |
DE68925226T2 (de) | Monoklonale Antikörper | |
ATA328286A (de) | Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa | |
ATA208987A (de) | Immortalisierte zellinie, verfahren zu ihrer herstellung und verfahren zur herstellung von monoklonalen antikörpern sowie diagnoseverfahren und -mittel | |
DE3668168D1 (de) | Desmosinderivate und reagenz zur herstellung artifizieller antigene. | |
ATA111789A (de) | Humaner monoklonaler antikörper und hybridom zur herstellung desselben | |
DE3583875D1 (de) | Verfahren zur herstellung von kugelfoermigen vollblut-erythrocyten und fixierung derselben. | |
DE58907880D1 (de) | Verfahren zur Herstellung aminierter Diketodi(het)aryl-pyrrolopyrrole und Verwendung derselben als photoleitfähige Substanzen. | |
DE3689868D1 (de) | Monoklonale Antikörper gegen menschliches Plasma-Prekallikrein und Verfahren zu ihrer Herstellung und Verwendung. | |
DE69728897D1 (de) | Saeugetierchemokine | |
DE3787706T2 (de) | Verfahren zur quantitativen Bestimmung der Antigene und Antikörper. | |
DE68910771D1 (de) | Verfahren zur Herstellung von verbessertem Proteinhydrolysat. | |
DE68912734T2 (de) | Verfahren zur Herstellung von Tetrafluoräthylen. | |
PT85830A (de) | Neue monoklonale antikorper gegen ifn-omega verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega | |
DE3750240D1 (de) | Gen, das ein Insektizid-Protein kodiert, und Herstellung des Proteins durch Verwendung dieses Gens. | |
DE3785175T2 (de) | A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung. | |
DE3850933D1 (de) | Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung. | |
DE3671603D1 (de) | Verfahren zur zucht von babesia canis, verwendung zur herstellung von antigenen und impfstoffen und antigene und impfstoffe gegen piroplasmose. | |
DE3683178D1 (de) | Methode zur herstellung monoklonaler antikoerper gegen plasminogenaktivatorfaktor. |